Chadwick Jeremy G bought KYMR
March 23, 2026 · Form 4 insider transaction
Chadwick Jeremy G bought 84,400 shares of Kymera Therapeutics, Inc. at $29.64 per share, a transaction worth $2.50M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
84,400
Price
$29.64
Total value
$2.50M
InsiderChadwick Jeremy G
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 23, 2026
Filing dateMarch 25, 2026
Shares owned after152,452
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.